SNT 8.33% 3.9¢ syntara limited

Ann: Ceasing to be a substantial holder from Arix Bioscience, page-71

  1. 7,125 Posts.
    lightbulb Created with Sketch. 546
    LOXL2 trial next year? so no partnership negotiation anymore?
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.